Hôpital Bretonneau

Tours 37044

0 studies enrolling now · 8 studies all time

What they study most

Alzheimer Disease, Amyotrophic Lateral Sclerosis, Cognitive Dysfunction, Dementia, Indolent Systemic Mastocytosis, Myelofibrosis, Oral Mucositis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Prostate Cancer Metastatic, Refractory Follicular Lymphoma

Studies at this site

• Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) — Running, not enrolling
• A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease — Stopped early
• Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma — Stopped early
• Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) — Completed
• Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis — Completed
• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed
• Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis — Completed
• Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis — Paused